Terms ending in 2032
Every in-force patent on F. Hoffmann-La Roche AG's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,779,150 | Novel Processes for the manufacture of Propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 8,828,990 | N-7 Substituted Purine and Pyrazolopyrimine Compounds, Compositions and Methods of Use In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 9,464,058 | New Imidazolylketone Derivatives In force · High confidence | Cincor Pharma, Inc. | In force | High confidence | |
| US 8,865,735 | Solid Forms of a Pharmaceutically Active Substance In force · High confidence | Hoffman-la Roche Inc. | In force | High confidence | |
| US 8,945,552 | Bispecific, Bivalent ANTI-VEGF/ANTI-ANG-2 Antibodies In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 8,703,132 | Bispecific, Tetravalent Antigen Binding Proteins In force · High confidence | Hoffmann-La Roche, Inc. | In force | High confidence | |
| US 9,676,845 | Bispecific Antigen Binding Proteins In force · High confidence | Hoffmann-La Roche, Inc. | In force | High confidence | |
| US 8,728,730 | Methods For Treating, Diagnosing, and Monitoring Rheumatoid Arthritis In force · High confidence | F. Hoffmann la-Roche AG | In force | High confidence | |
| US 9,187,429 | Phenyl-Tetrahydroisoquinoline Derivatives In force · High confidence | Cincor Pharma, Inc. | In force | High confidence | |
| US 9,107,836 | Formulation In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| 38 more term ends in 2032 · Pro | |||||
10 of 48 patents shown. Soonest term end first, then patent number.
Pro members see all 48.
8 of these are in force and held by F. Hoffmann-La Roche AG.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.